dr5

DR5 Antibody

49563-50ul 50ul
EUR 239

DR5 Antibody

abx037475-100ug 100 ug
EUR 391

DR5 Antibody

abx037826-100ug 100 ug
EUR 391

DR5 Antibody

20-abx007808
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul

DR5 Antibody

DF6368 200ul
EUR 304
Description: DR5 Antibody detects endogenous levels of total TNFRSF10B.

anti-DR5

YF-PA15867 50 ug
EUR 363
Description: Mouse polyclonal to DR5

anti-DR5

YF-PA15868 100 ul
EUR 403
Description: Rabbit polyclonal to DR5

anti-DR5

YF-PA15869 100 ug
EUR 403
Description: Rabbit polyclonal to DR5

DR5 Antibody

3062-100
EUR 316

DR5 Antibody

3062-30T
EUR 146

anti-DR5

YF-PA25186 50 ul
EUR 334
Description: Mouse polyclonal to DR5

DR5 antibody

10R-6672 100 ug
EUR 349
Description: Mouse monoclonal DR5 antibody

DR5 antibody

10R-6673 100 ug
EUR 349
Description: Mouse monoclonal DR5 antibody

DR5 Antibody

2019-002mg 0.02 mg
EUR 171.82
Description: DR5 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family. DR4 was recently identified as the receptor for TRAIL. A novel death domain containing receptor for TRAIL was more recently identified and designated DR5, Apo2, TRAIL-R2, TRICK2, or KILLER by several groups independently. Like DR4, DR5 transcript is widely expressed in normal tissues and in many types of tumor cells. DR5 binds to TRAIL and mediates TRAIL induced cell death. Overexpression of DR5 induces apoptosis and activates NF-κB.

DR5 Antibody

2019-01mg 0.1 mg
EUR 436.42
Description: DR5 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family. DR4 was recently identified as the receptor for TRAIL. A novel death domain containing receptor for TRAIL was more recently identified and designated DR5, Apo2, TRAIL-R2, TRICK2, or KILLER by several groups independently. Like DR4, DR5 transcript is widely expressed in normal tissues and in many types of tumor cells. DR5 binds to TRAIL and mediates TRAIL induced cell death. Overexpression of DR5 induces apoptosis and activates NF-κB.

DR5 Peptide

2019P 0.05 mg
EUR 164.75
Description: (CT) DR5 peptide

DR5 antibody

70R-11591 100 ug
EUR 403
Description: Rabbit polyclonal DR5 antibody

DR5 antibody

70R-51347 100 ul
EUR 244
Description: Purified Polyclonal DR5 antibody

Monoclonal DR5 Antibody

AMM03174G 0.1ml
EUR 484
Description: A Monoclonal antibody against Human DR5. The antibodies are raised in Mouse. This antibody is applicable in WB, ICC

Monoclonal DR5 Antibody

AMM03175G 0.1ml
EUR 484
Description: A Monoclonal antibody against Human DR5. The antibodies are raised in Mouse. This antibody is applicable in WB

Monoclonal DR5 Antibody

AMM03176G 0.1ml
EUR 484
Description: A Monoclonal antibody against Human DR5. The antibodies are raised in Mouse. This antibody is applicable in WB

Anti-DR5 antibody

STJ16100937 100 µg
EUR 524

Polyclonal DR5 Antibody

APR00016G 0.1mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DR5 . This antibody is tested and proven to work in the following applications:

Polyclonal DR5 Antibody

APR06238G 0.1 mg
EUR 659
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DR5 . This antibody is tested and proven to work in the following applications:

DR5 Monoclonal Antibody

27200-100ul 100ul
EUR 252

DR5 Monoclonal Antibody

27200-50ul 50ul
EUR 187

DR5 Blocking Peptide

20-abx064222
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg

DR5 Rabbit mAb

A19043-100ul 100 ul
EUR 410

DR5 Rabbit mAb

A19043-200ul 200 ul
EUR 571

DR5 Rabbit mAb

A19043-20ul 20 ul
EUR 221

DR5 Rabbit mAb

A19043-50ul 50 ul
EUR 287

DR5-Specific Antibody

abx232530-100ug 100 ug
EUR 551

Anti-DR5 antibody

STJ99180 200 µl
EUR 197
Description: Mouse monoclonal to DR5.

Anti-DR5 antibody

STJ99181 200 µl
EUR 197
Description: Mouse monoclonal to DR5.

Anti-DR5 antibody

STJ99182 200 µl
EUR 197
Description: Mouse monoclonal to DR5.

DR5 Blocking Peptide

DF6368-BP 1mg
EUR 195

Anti-DR5 (2D6)

YF-MA16522 100 ug
EUR 363
Description: Mouse monoclonal to DR5

DR5 Blocking Peptide

3062BP-50
EUR 153

DR5 antibody (PE)

61R-1368 100 ug
EUR 403
Description: Armenian Hamster monoclonal DR5 antibody (PE)

DR5 antibody (biotin)

61R-1609 100 ug
EUR 435
Description: Armenian Hamster monoclonal DR5 antibody (biotin)

DR5 antibody (biotin)

61R-1672 100 ug
EUR 435
Description: Mouse monoclonal DR5 antibody (biotin)

DR5 Blocking Peptide

33R-10614 50 ug
EUR 191
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DR5 antibody, catalog no. 70R-11591

DR5 Recombinant Protein

96-749 0.1 mg
EUR 516.5
Description: Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) is also known as TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2), Death receptor 5 (DR5), CD262, KILLER, is a member of the TNF-receptor superfamily, and contains an intracellular death domain. TNFRSF10B / DR-5 is widely expressed in adult and fetal tissues; very highly expressed in tumor cell lines. TRAILR2 / CD262 / DR5 is the receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD (a death domain containing adaptor protein) of TRAIL-R2 / TNFRSF10B recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. CD262 / DR5 Promotes the activation of NF-kappa-B. DR5 is essential for ER stress-induced apoptosis and is regulated by p53/TP53.

DR5 Recombinant Protein

96-750 0.1 mg
EUR 516.5
Description: Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) is also known as TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2), Death receptor 5 (DR5), CD262, KILLER, is a member of the TNF-receptor superfamily, and contains an intracellular death domain. TNFRSF10B / DR-5 is widely expressed in adult and fetal tissues; very highly expressed in tumor cell lines. TRAILR2 / CD262 / DR5 is the receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD (a death domain containing adaptor protein) of TRAIL-R2 / TNFRSF10B recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. CD262 / DR5 Promotes the activation of NF-kappa-B. DR5 is essential for ER stress-induced apoptosis and is regulated by p53/TP53.

Recombinant Human DR5 Protein

RP00282 10 μg
EUR 149

Anti-DR5/TNFRSF10B Antibody

PA1842 100ug/vial
EUR 334

Anti-DR5/TNFRSF10B Antibody

A00410 100ug/vial
EUR 334

anti- DR5-Specific antibody

FNab02530 100µg
EUR 585
Description: Antibody raised against DR5-Specific

DR5 Conjugated Monoclonal Antibody

C27200 100ul
EUR 397

Anti-DR5-Specific antibody

PAab02530 100 ug
EUR 412

Anti-DR5 Rabbit Monoclonal Antibody

M00410 100ug/vial
EUR 397
Description: Rabbit Monoclonal DR5 Antibody. Validated in IP, WB and tested in Human.

pGL3-Basic-DR5 promoter Plasmid

PVTB00791-2a 2 ug
EUR 356

pGreenIIM DR5v2-ntdTomato-DR5-n3GFP

PVT17730 2 ug
EUR 341

CTLD scaffold protein anti-Human DR5

SCl-L067 1 mg
EUR 4496
Description: Scaffold protein

TRAIL R2 / DR5 / TNFRSF10B Recombinant Protein

11-183 0.1 mg
EUR 516.5
Description: Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) is also known as TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2), Death receptor 5 (DR5), CD262, KILLER, is a member of the TNF-receptor superfamily, and contains an intracellular death domain. TNFRSF10B / DR-5 is widely expressed in adult and fetal tissues; very highly expressed in tumor cell lines. TRAILR2 / CD262 / DR5 is the receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD (a death domain containing adaptor protein) of TRAIL-R2 / TNFRSF10B recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. CD262 / DR5 Promotes the activation of NF-kappa-B. DR5 is essential for ER stress-induced apoptosis and is regulated by p53/TP53.

TRAIL R2 / DR5 / TNFRSF10B Recombinant Protein

11-359 0.1 mg
EUR 516.5
Description: Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) is also known as TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2), Death receptor 5 (DR5), CD262, KILLER, is a member of the TNF-receptor superfamily, and contains an intracellular death domain. TNFRSF10B / DR-5 is widely expressed in adult and fetal tissues; very highly expressed in tumor cell lines. TRAILR2 / CD262 / DR5 is the receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD (a death domain containing adaptor protein) of TRAIL-R2 / TNFRSF10B recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. CD262 / DR5 Promotes the activation of NF-kappa-B. DR5 is essential for ER stress-induced apoptosis and is regulated by p53/TP53.

Recombinant human TRAIL-R2 (DR5)/Fc Chimera

EXB0007 0.05 mg
EUR 304

Polyclonal TNFRSF10B / Killer / DR5 Antibody (aa388-407)

APR02475G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TNFRSF10B / Killer / DR5 (aa388-407). This antibody is tested and proven to work in the following applications:

Polyclonal TNFRSF10B / Killer / DR5 Antibody (aa380-398)

APR02728G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TNFRSF10B / Killer / DR5 (aa380-398). This antibody is tested and proven to work in the following applications:

Recombinant Mouse TRAIL R2/TNFRSF10B/DR5/CD262 (C-Fc)

CI97-10ug 10ug
EUR 146
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse TRAIL R2/TNFRSF10B/DR5/CD262 (C-Fc)

CI97-1mg 1mg
EUR 2283
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse TRAIL R2/TNFRSF10B/DR5/CD262 (C-Fc)

CI97-500ug 500ug
EUR 1613
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse TRAIL R2/TNFRSF10B/DR5/CD262 (C-Fc)

CI97-50ug 50ug
EUR 303
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human TRAIL R2/TNFRSF10B/DR5/CD262 (C-6His)

C326-10ug 10ug
EUR 90
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human TRAIL R2/TNFRSF10B/DR5/CD262 (C-6His)

C326-1mg 1mg
EUR 1166
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human TRAIL R2/TNFRSF10B/DR5/CD262 (C-6His)

C326-500ug 500ug
EUR 831
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human TRAIL R2/TNFRSF10B/DR5/CD262 (C-6His)

C326-50ug 50ug
EUR 171
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Mouse TRAIL R2/TNFRSF10B/DR5/CD262 (C-Avi-6His)

CP95-10ug 10ug
EUR 100
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse TRAIL R2/TNFRSF10B/DR5/CD262 (C-Avi-6His)

CP95-1mg 1mg
EUR 1166
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse TRAIL R2/TNFRSF10B/DR5/CD262 (C-Avi-6His)

CP95-500ug 500ug
EUR 811
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.